4-Methyl-5-(3-(trifluoromethyl)-1H-pyrazol-1-yl)thiazol-2-amine

Catalog No. :
ACJOZK330
CAS No. :
1006348-68-0
Molecular Formula :
C8H7F3N4S
Molecular Weight :
248.23

IUPAC Name:4-methyl-5-(3-(trifluoromethyl)-1H-pyrazol-1-yl)thiazol-2-amine

4-Methyl-5-(3-(trifluoromethyl)-1H-pyrazol-1-yl)thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$146.00Login to see priceInquiryInquiry
100mg97%$213.00Login to see priceInquiryInquiry
250mg97%$299.00Login to see priceInquiryInquiry
1g97%$596.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-5-(3-(trifluoromethyl)-1H-pyrazol-1-yl)thiazol-2-amine
IUPAC Name4-methyl-5-(3-(trifluoromethyl)-1H-pyrazol-1-yl)thiazol-2-amine
MDL No.MFCD08558209
Molecular FormulaC8H7F3N4S
Molecular Weight248.23
SMILESNC1=NC(C)=C(N2N=C(C(F)(F)F)C=C2)S1
InChI KeyJGGXTJSNPHMHSG-UHFFFAOYSA-N
Synonym4-Methyl-5-[3-(trifluoromethyl)-1H-pyrazol-1-yl]-1,3-thiazol-2-amine;2-Thiazolamine, 4-methyl-5-[3-(trifluoromethyl)-1H-pyrazol-1-yl]-
CAS No.1006348-68-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJOZK330 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDAEB876 route compound structure diagram
    ACDAEB8763034-58-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJOZK330 route product structure diagram
    ACJOZK3301006348-68-0
Inquiry

2. ACJOZK330 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJOZK330 route product structure diagram
    ACJOZK3301006348-68-0
Inquiry

Comments (0)